Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $319.6100 (-2.73%) ($316.5700 - $326.5000) on Fri. Apr. 6, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.18% (three month average) | RSI | 37 | Latest Price | $319.6100(-2.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.5% a day on average for past five trading days. | Weekly Trend | REGN declines -0.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(50%) IVW(43%) IWF(43%) QQQ(43%) | Factors Impacting REGN price | REGN will decline at least -1.09% in a week (0% probabilities). UUP(-10%) TLT(-6%) VIXM(-5%) TIP(-1%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.09% (StdDev 2.18%) | Hourly BBV | 0 () | Intraday Trend | -1.4% | | | |
|
Resistance Level | $334.33 | 5 Day Moving Average | $329.66(-3.05%) | 10 Day Moving Average | $331.21(-3.5%) | 20 Day Moving Average | $334.33(-4.4%) | To recent high | -18.4% | To recent low | 1.2% | Market Cap | $33.888b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |